Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.

Author: BrandtJohn T, FaridNagy A, LiYing G, PayneChristopher D, SalazarDaniel E, SmallDavid S, WeerakkodyGovinda J, WintersKenneth J

Paper Details 
Original Abstract of the Article :
Prasugrel and clopidogrel, thienopyridine prodrugs, are each metabolized to an active metabolite that inhibits the platelet P2Y(12) ADP receptor. In this open-label, 4-period crossover study, the effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasug...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1177/0091270008315310

データ提供:米国国立医学図書館(NLM)

Lansoprazole's Influence on Prasugrel and Clopidogrel Pharmacokinetics

As researchers, we are always seeking to understand the intricate interactions between medications and their potential impact on patient outcomes. This study delves into the complex world of drug interactions, exploring the effects of lansoprazole, a proton pump inhibitor, on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel, two antiplatelet agents used to prevent blood clots. The researchers conducted a study to assess the impact of lansoprazole on the activity of these antiplatelet medications, examining their absorption, metabolism, and effectiveness in inhibiting platelet aggregation.

Lansoprazole's Impact on Antiplatelet Medication Activity

The study found that lansoprazole decreased the exposure of prasugrel's active metabolite, but did not significantly affect its ability to inhibit platelet aggregation. However, lansoprazole tended to lower the platelet aggregation inhibition by clopidogrel. This suggests that lansoprazole may have a different impact on the activity of prasugrel and clopidogrel, highlighting the importance of considering these interactions when prescribing these medications.

Navigating the Desert of Drug Interactions

This study highlights the importance of considering drug interactions when prescribing medications, particularly those that affect critical physiological processes like platelet aggregation. It emphasizes the need for careful evaluation of potential interactions to ensure patient safety and optimize treatment outcomes. It's like navigating a vast desert where each step must be carefully considered to avoid potential dangers.

Dr. Camel's Conclusion

This research serves as a reminder that the desert of drug interactions can be complex and unpredictable. It underscores the importance of thorough medication reviews and careful consideration of potential interactions to ensure the safety and effectiveness of prescribed therapies.

Date :
  1. Date Completed 2008-05-28
  2. Date Revised 2022-03-30
Further Info :

Pubmed ID

18303127

DOI: Digital Object Identifier

10.1177/0091270008315310

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.